Relationship between inflammation and the severity of Recurrent Respiratory Papillomatosis

https://doi.org/10.1016/j.amjoto.2019.102321Get rights and content

Highlights

  • There is difference between inflammatory cell population in juvenile and adult recurrent respiratory pappilomatosis.

  • Adults showed significantly higher quantities of CD3+, CD8+ and MUM1+ cells than the juvenile patients.

  • MUM-1+ cells were correlated with lower Derkay index.

Abstract

Objective

To characterize inflammatory cells in Recurrent Respiratory Papillomatosis (RRP) and to correlate it with severity using the Derkay laryngoscopic scale.

Materials and methods

The data and biopsies from 36 patients with Juvenile (JRRP) and 56 patients with Adult (ARRP) were collected and analyzed under light microscopy. The patients were separated into groups according to the Derkay index: ≥20 for the most severe and < 20 for the less severe cases. Immunohistochemical analysis using CD3, CD4, CD8, CD15, CD20, CD68, FoxP3 and MUM-1 antibodies was performed, and the inflammatory cells were quantified. All the clinicopathological characteristics and the results of the immunohistochemical analysis were compared among the groups proposed using the Chi-Square test and correlated through the Spearman correlation test.

Results

The ARRP showed significantly higher quantities of CD3+, CD8+ and MUM1+ cells (p < .05) than the JRRP samples. The presence of CD15+ cells showed positive correlation with the Derkay index (p < .05), while the MUM-1+ cells showed an inverse correlation (p = .01).

Conclusion

There are differences between the inflammatory cells population in the juvenile and adult groups and it can be related to disease severity.

Introduction

Recurrent Respiratory Papillomatosis (RRP) is a serious disease that occurs in two clinical forms: juvenile (JRRP) and adult (ARRP); the former occurs predominantly before 5 years of age and affects both females and males equally; the latter is prevalent in male patients between 20 and 40 years of age [1].

Human papillomavirus (HPV) infection is responsible for the development of the disease, primarily the low-risk types HPV 6 and 11 [1,2]. HPV type 6 is the most common [3,4] and type 11 is predominant in the most aggressive cases [1,5].

There are scales that assist in therapeutic decision-making and in the identification of aggressive cases, including: Voice Handicap Index-10 (VHI-10) [6], Roughness, Breathiness, Asthenia, Strain (GRBAS) [7] and the laryngoscopic scale of Derkay et al. (1998) [8].

The immune system is important in preventing lesion progression and encouraging HPV-infection clearance [9]. There are few studies correlating the aggressiveness of RRP to inflammation and the results are not uniform [10,11]. The severity of RRP has been correlated with greater numbers of CD83+ mature dendritic cells (DC) in the epithelium and there is evidence of the involvement of migration of these cells and their retention in the epithelial layer [11]. In RRP, the imbalance between Th1 and Th2 immune responses may contribute to the persistence of infection and recurrence of this disease [10].

Noting the important role of inflammation, or its absence, related to the above-mentioned disease, the present study aims to identify possible differences in the population of inflammatory cells secreting pro-inflammatory cytokines and chemokines between patients with low and high Derkay indexes.

The results may detect prognostic factors that lead to the early recognition of aggressive cases, and also determine possible causes that lead to the varied behavior of this disease that may occur in isolated cases, multiple relapses or spontaneous remission.

Section snippets

Samples

Retrospective samples of JRRP and ARRP were collected at different centers: 3 samples from the Pediatric Otorhinolaryngology Outpatient Clinic of the Paulista Medical School/UNIFESP; 70 from the Ribeirão Preto Medical School/USP and 19 from the Head and Neck Clinical Center in Guatemala. A total of 36 juvenile samples and 56 adults' samples were used, of which 46 were from Brazil and 10 from Guatemala, and the sampling period was from 1997 to 2016. The Research Ethical Committee of the São

Clinical findings

From the clinical data, for the juvenile group, the mean age was 4.94 years, ranging from 1 to 15 years, with 18 (50.00%) cases in males and 18 (50.00%) in females (ratio of 1:1). Additionally, 6 (16.67%) patients received some adjuvant treatment and 1 (2.78%) patient was receiving treatment for asthma, and 6 (18.18%) required tracheostomy.

The mean age of the adult group was 41.62 years, ranging from 19 to 74 years of age; 24 (50%) patients were over 40 years old, with 41 (73.21%) cases in

Discussion

RRP is an uncommon disease that can develop a severe clinical course leading to death [1,18]. Such aggressiveness is related to age, time of evolution and type of HPV [19,20]. Additionally, the immune system may also play an important role in the clinical course of the disease [11].

CD3+ T cells represents the total number of T lymphocytes [17]. In the present study, these cells were present in greater numbers in adult patients; the group that presented less severe RRP. CD3+ T cells are

Conclusion

In summary, our results found a correlation of CD3+ and CD8+ cells with low-grade dysplasia and CD68+ with high-grade dysplasia. In more severe cases of JRRP, a smaller quantity of CD3+, CD8+ and MUM1+ cells was observed. The immune system imbalance can play an important role in the severity of RRP.

Funding

For the financial support received from FAPESP (São Paulo Research Foundation, Grant: 16/24019-0 to EK) and CAPES (Coordination for the Improvement of Higher Education Personnel to VNREA).

Declaration of competing interest

All the authors declare that there is no conflict of interest.

References (35)

  • KJ Auborn et al.

    Replicative intermediates of human papillomavirus type 11 in laryngeal papillomas: site of replication initiation and direction of replication

    Proc Natl Acad Sci U S A

    (1994)
  • I Vancurova et al.

    Increased p50/p50 NF-KB activation in human papillomavirus type 6- or type 11-induced laryngeal papilloma tissue

    J Virol

    (2002)
  • P Mounts et al.

    Association of human papillomavirus subtype and clinical course in respiratory papillomatosis

    Laryngoscope

    (1984)
  • CA Rosen et al.

    Development and validation of the voice handicap index-10

    Laryngoscope

    (2004)
  • CS Derkay et al.

    A staging system for assessing severity of disease and response to therapy in recurrent respiratory papillomatosis

    Laryngoscope

    (1998)
  • KLF Alvarez et al.

    Local and systemic immunomodulatory mechanisms triggered by human papillomavirus transformed cells: a potential role for G-CSF and neutrophils

    Sci Rep

    (2017)
  • JA DeVoti et al.

    Immune dysregulation and tumor-associated gene changes in recurrent respiratory papillomatosis: a paired microarray analysis

    Mol Med

    (2008)
  • View full text